NCT01897220

Brief Summary

The aim of the study is to analyze the present use of antithrombotic therapy on a large cohort of consecutive cardiacs undergoing non-cardiac surgery. If even and for how long the medication was discontinued, if any other antithrombotic therapy was used in the perioperative period and prevalence of perioperative complications - especially ischemic or bleeding. These complications will be correlated with the pattern of antithrombotic therapy administration. Working hypothesis is to obtain a large database of unselected cohort of consecutive patients for mapping of this practically important, but in the evidence-based medicine, still neglected problem.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2011

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2011

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2013

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

June 27, 2013

Completed
14 days until next milestone

First Posted

Study publicly available on registry

July 11, 2013

Completed
Last Updated

February 1, 2019

Status Verified

January 1, 2019

Enrollment Period

1.5 years

First QC Date

June 27, 2013

Last Update Submit

January 30, 2019

Conditions

Keywords

Noncardiac surgery;Perioperative ischemic complications;Perioperative bleeding complications;Antithrombotic therapy;Coronary artery disease;Stent thrombosis;Perioperative infarction.

Outcome Measures

Primary Outcomes (1)

  • Prevalence of perioperative complications - especially ischemic or bleeding

    Prevalence of perioperative complications - especially ischemic or bleeding; These complications will be correlated with the pattern of antithrombotic therapy administration.

    Participants will be followed for the duration of hospital stay, an expected average of 10 days

Study Arms (1)

University Hospital Patients

Consecutive patients with cardiovascular disease(s) undergoing non-cardiac surgery

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Unselected cohort of consecutive patients undergoing non-cardiac surgery in four surgical clinics of the University Hospital.

You may qualify if:

  • Any kind of non-cardiac surgery (acute or elective) performed under general or neuraxial anaesthesia in four surgical departments - General surgery, Orthopedics-Trauma, Urology and Neurosurgery.
  • History of cardiovascular disease with risk of arterial, intracardiac or vein thrombosis or embolism. (3) Signed Informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Cardiocentre, Univ. Hospital Kralovske Vinohrady

Prague, 10034, Czechia

Location

Cardiocentre, Univ. Hospital Královské Vinohrady

Prague, 10034, Czechia

Location

Related Publications (1)

  • Ondrakova M, Motovska Z, Waldauf P, Knot J, Havluj L, Bittner L, Bartoska R, Gurlich R, Krbec M, Dzupa V, Grill R, Widimsky P. Antithrombotic therapy of patients with atrial fibrillation discharged after major non-cardiac surgery. 1-year follow-up. Sub-analysis of PRAGUE 14 study. PLoS One. 2017 May 24;12(5):e0177519. doi: 10.1371/journal.pone.0177519. eCollection 2017.

Related Links

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Petr Widimsky, Prof.

    Cardiocentre, Univ. Hospital Královské Vinohrady, Prague, Czech Rep.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Week
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 27, 2013

First Posted

July 11, 2013

Study Start

December 1, 2011

Primary Completion

June 1, 2013

Study Completion

June 1, 2013

Last Updated

February 1, 2019

Record last verified: 2019-01

Locations